Revance Therapeutics, Inc. (RVNC) SEC filings
RVNC SEC filings moved a median of -0.16% by the close. RVNC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RVNC overview →
42 measured RVNC SEC filing events.
Where these RVNC SEC filings landedvs 38 measured RVNC SEC filing reactions
| Middle 50% of RVNC SEC filing reactions | -4.26% to +2.26% |
|---|---|
| Median reaction (to close) | -0.16% |
| Measured reactions | 38 |
Point-in-time · zero look-ahead
Half of the 38 RVNC SEC filing events with a measured close landed between -4.26% and +2.26%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Revance Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form POSASR Revance Therapeutics, | SEC filing · Form POSASR | — | — | |
| Form S-8 POS Revance Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K Revance Therapeutics, For: Feb 06 | SEC filing · Form 8-K | — | — | |
| Form 8-K Revance Therapeutics, For: Jan 17 | SEC filing · Form 8-K | +0.14% | +0.82% | |
| Form 8-K Revance Therapeutics, For: Dec 11 | SEC filing · Form 8-K | -0.01% | +0.00% | |
| Form 8-K Revance Therapeutics, For: Dec 07 | SEC filing · Form 8-K | -0.54% | -0.33% | |
| Form 8-K Revance Therapeutics, For: Dec 05 | SEC filing · Form 8-K | +0.77% | -1.55% | |
| Form 8-K Revance Therapeutics, For: Dec 03 | SEC filing · Form 8-K | +4.49% | +0.51% | |
| Form 8-K Revance Therapeutics, For: Nov 29 | SEC filing · Form 8-K | +3.41% | -1.64% | |
| Form 8-K Revance Therapeutics, For: Nov 26 | SEC filing · Form 8-K | +0.25% | +1.26% | |
| Form 8-K Revance Therapeutics, For: Nov 19 | SEC filing · Form 8-K | -4.08% | -3.06% | |
| Form 8-K Revance Therapeutics, For: Nov 12 | SEC filing · Form 8-K | +3.00% | +8.83% | |
| Form 10-Q Revance Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.95% | -12.53% | |
| Form 8-K Revance Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -0.95% | -12.53% | |
| Form 8-K Revance Therapeutics, For: Nov 01 | SEC filing · Form 8-K | -4.42% | -1.36% | |
| Form 8-K Revance Therapeutics, For: Oct 24 | SEC filing · Form 8-K | -0.50% | -1.67% | |
| Form 8-K Revance Therapeutics, For: Oct 18 | SEC filing · Form 8-K | +0.19% | +1.54% | |
| Form 8-K Revance Therapeutics, For: Oct 03 | SEC filing · Form 8-K | +0.19% | -0.57% | |
| Form 8-K Revance Therapeutics, For: Sep 19 | SEC filing · Form 8-K | +1.26% | +4.38% | |
| Form 8-K Revance Therapeutics, For: Sep 09 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Revance Therapeutics, For: Aug 27 | SEC filing · Form 8-K | +0.08% | +0.00% | |
| Form 8-K Revance Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -0.23% | +0.76% | |
| Form 8-K Revance Therapeutics, For: Aug 08 | SEC filing · Form 8-K | +10.97% | +13.87% | |
| Form 10-Q Revance Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +10.97% | +13.87% | |
| Form 8-K Revance Therapeutics, For: Aug 08 | SEC filing · Form 8-K | +10.97% | +13.87% | |
| Form 10-Q Revance Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -9.88% | -18.02% | |
| Form 8-K Revance Therapeutics, For: May 09 | SEC filing · Form 8-K | -9.88% | -18.02% | |
| Form 8-K Revance Therapeutics, For: May 01 | SEC filing · Form 8-K | +0.00% | +2.50% | |
| Form DEF 14A Revance Therapeutics, For: May 01 | SEC filing · Form DEF | -1.17% | -5.62% | |
| Form DEFA14A Revance Therapeutics, | SEC filing · Form DEFA14A | -1.17% | -5.62% | |
| Form 8-K Revance Therapeutics, For: Mar 04 | SEC filing · Form 8-K | -0.90% | -4.66% | |
| Form S-8 Revance Therapeutics, | SEC filing · Form S-8 | +1.46% | +16.10% | |
| Form 10-K Revance Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.46% | +16.10% | |
| Form 8-K Revance Therapeutics, For: Feb 23 | SEC filing · Form 8-K | +1.46% | +16.10% | |
| Form 8-K Revance Therapeutics, For: Feb 07 | SEC filing · Form 8-K | +0.56% | +3.72% | |
| Form 8-K Revance Therapeutics, For: Jan 31 | SEC filing · Form 8-K | -3.15% | -8.81% | |
| Form 8-K Revance Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -1.66% | -2.76% | |
| Form 8-K Revance Therapeutics, For: Dec 12 | SEC filing · Form 8-K | -0.99% | -2.47% | |
| Form S-3ASR Revance Therapeutics, | SEC filing · Form S-3ASR | +2.46% | +1.45% | |
| Form 10-Q Revance Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +10.75% | -5.99% | |
| Form 8-K Revance Therapeutics, For: Nov 08 | SEC filing · Form 8-K | +10.75% | -5.99% |
Keep exploring
More RVNC: earnings → · analyst actions → · RVNC overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PishPosh, Inc. (BABY) | 702 | 0.00% | 48% |
| Insmed Incorporated (INSM) | 701 | -0.08% | 45% |
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
| STEMLINE THERAPEUTICS (STML) | 697 | +0.08% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.